Julie Gerberding

Julie Gerberding

Directeur/Membre du Conseil chez MCKESSON CORPORATION

Fortune : - $ au 31/05/2026

71 ans
Health Technology
Commercial Services
Health Services

Profil

Julie Louise Gerberding is President, Chief Executive Officer & Director at Foundation for the National Institutes of Health, Inc. since 2022.
Holds director positions at Biotechnology Innovation Organization, Accordia Global Health Foundation since 2009, MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. since 2010, SummerBio LLC since 2022, and Independent Director at McKesson Corp.
starting 2025.
Serves as Trustee at Case Western Reserve University and Mayo Clinic since 2022.
Member of National Academy of Public Administration and National Academy of Medicine (United States).
Formerly Independent Director at Cerner Corp.
from 2017 to 2022.
Director at Centers for Disease Control & Prevention from 2002 to 2009.
Co-Chairman at MSD Vaccines Ltd. Executive Vice President-Strategic Communications at Merck & Co., Inc. from 2015 to 2016.
President of Merck Vaccine Division from 2010 to 2014.
Director at Project HOPE-The-People-To-People Health Foundation, Inc. Independent Director at HilleVax, Inc. from 2021 to 2025.
Independent Director at AfterNext HealthTech Acquisition Corp.
Education includes undergraduate and doctorate degrees from Case Western Reserve University and a graduate degree from the University of California, Berkeley conferred in 1990.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
30/07/2025 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Julie Gerberding

SociétésPosteDébut
MCKESSON CORPORATION Directeur/Membre du Conseil 03/02/2025
Directeur/Membre du Conseil 01/01/2022
Directeur/Membre du Conseil 16/03/2022
Corporate Officer/Principal -
Directeur Général 16/05/2022
Directeur/Membre du Conseil 01/01/2010
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Julie Gerberding

SociétésPosteFin
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Julie Gerberding

Formation de Julie Gerberding

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

72

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Technology Services

Distribution Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Services

Government

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Miscellaneous

Merck Vaccine Division

Health Technology

Health Services

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Julie Gerberding
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇